{
    "root": "2ac009f2-257f-4603-a1e8-c50aa9e31f4b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "NITROGLYCERIN",
    "value": "20241015",
    "ingredients": [
        {
            "name": "NITROGLYCERIN",
            "code": "G59M7S0WS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28787"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "GLYCERYL MONOSTEARATE",
            "code": "230OU9XXE4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11250"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_190296"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        }
    ],
    "indications": {
        "text": "nitroglycerin sublingual tablets indicated acute relief attack acute prophylaxis angina pectoris due coronary artery disease .",
        "doid_entities": [
            {
                "text": "coronary artery disease (DOID:3393)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3393"
            },
            {
                "text": "artery disease (DOID:0050828)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050828"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "administer one tablet tongue buccal pouch first sign acute anginal attack . allow tablet dissolve without swallowing . one additional tablet may administered every 5 minutes relief obtained . three tablets recommended within 15-minute period . pain persists total 3 tablets 15-minute period , pain different typically experienced , seek prompt medical attention . nitroglycerin sublingual tablets may used prophylactically 5 10 minutes prior engaging activities might precipitate acute attack . patients xerostomia , small sip water prior placing tablet tongue may help maintain mucosal hydration aid dissolution tablet . administer nitroglycerin sublingual tablets rest , preferably sitting position .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "nitroglycerin sublingual tablets supplied white , round , flat-faced tablets 3 strengths ( 0.3 mg , 0.4 mg , 0.6 mg ) bottles containing 100 tablets , color-coded labels , color-coded patient convenience packages 4 bottles 25 tablets . 0.3 mg : coded \u201c n \u201d one side \u201c 3 \u201d . ndc 59762-4921-1\u2014bottle 100 tablets 0.4 mg : coded \u201c n \u201d one side \u201c 4 \u201d . ndc 59762-3304-2\u2014bottle 25 tablets ndc 59762-3304-3\u2014convenience package carton 4 bottles 25 tablets ndc 59762-3304-1\u2014bottle 100 tablets 0.6 mg : coded \u201c n \u201d one side \u201c 6 \u201d . ndc 59762-0489-1\u2014bottle 100 tablets store controlled room temperature 20\u00b0\u201325\u00b0c ( 68\u00b0\u201377\u00b0f ) [ usp ] . nitroglycerin kept original glass container must tightly capped prevent loss tablet potency .",
    "adverseReactions": "\u2022 phosphodiesterase type 5 ( pde-5 ) inhibitors , avanafil , sildenafil , tadalafil , vardenafil , soluble guanylate cyclase ( sgc ) stimulators . ( 4.1 , 7.1 ) \u2022 severe anemia ( 4.2 ) \u2022 increased intracranial pressure ( 4.3 ) \u2022 hypersensitivity nitroglycerin nitrates nitrites excipient ( 4.4 ) \u2022 circulatory failure shock ( 4.5 )",
    "indications_original": "Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.",
    "contraindications_original": "Administer one tablet under the tongue or in the buccal pouch at the first sign of an acute anginal attack. Allow tablet to dissolve without swallowing. One additional tablet may be administered every 5 minutes until relief is obtained. No more than three tablets are recommended within a 15-minute period. If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, seek prompt medical attention.\n                  Nitroglycerin sublingual tablets may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack.\n                  For patients with xerostomia, a small sip of water prior to placing the tablet under the tongue may help maintain mucosal hydration and aid dissolution of the tablet. \n                  Administer nitroglycerin sublingual tablets at rest, preferably in the sitting position.",
    "warningsAndPrecautions_original": "Nitroglycerin Sublingual Tablets are supplied as white, round, flat-faced tablets in 3 strengths (0.3 mg, 0.4 mg, and 0.6 mg) in bottles containing 100 tablets each, with color-coded labels, and in color-coded Patient Convenience Packages of 4 bottles of 25 tablets each.\n                  \u00a0\u00a0\u00a00.3 mg: Coded \u201cN\u201d on one side and \u201c3\u201d on the other.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 59762-4921-1\u2014Bottle of 100 tablets\n                  \u00a0\u00a0\u00a00.4 mg: Coded \u201cN\u201d on one side and \u201c4\u201d on the other.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 59762-3304-2\u2014Bottle of 25 tablets\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 59762-3304-3\u2014Convenience Package Carton of 4 Bottles of 25 tablets\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 59762-3304-1\u2014Bottle of 100 tablets\n                  \u00a0\u00a0\u00a00.6 mg: Coded \u201cN\u201d on one side and \u201c6\u201d on the other.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 59762-0489-1\u2014Bottle of 100 tablets\n                  Store at Controlled Room Temperature 20\u00b0\u201325\u00b0C (68\u00b0\u201377\u00b0F) [see USP]. Nitroglycerin should be kept in the original glass container and must be tightly capped after each use to prevent loss of tablet potency.",
    "adverseReactions_original": "\u2022 Use of phosphodiesterase type 5 (PDE-5) inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulators. ( 4.1 , 7.1 ) \u2022 Severe anemia ( 4.2 ) \u2022 Increased intracranial pressure ( 4.3 ) \u2022 Hypersensitivity to nitroglycerin or to other nitrates or nitrites or any excipient ( 4.4 ) \u2022 Circulatory failure and shock ( 4.5 )",
    "drug": [
        {
            "name": "NITROGLYCERIN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28787"
        }
    ]
}